Flinders University is a public research university in Adelaide, South Australia. Founded in 1966, it was named in honour of British navigator Matthew Flinders, who explored and surveyed the South Australian coastline in the early 19th century.

During the past decade, Flinders University conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Flinders University" #1 sponsor was "Vaxine Pty Ltd" with 3 trials, followed by "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored, "BRC Operations Pty. Ltd." with 1 trials sponsored, "Great Ormond Street Hospital for Children NHS Foundation Trust" with 1 trials sponsored and "PureTech" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Flinders University" #1 collaborator was "Australian Respiratory and Sleep Medicine Institute" with 3 trials as a collaborator, "Flinders University" with 3 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Asociacion Benefica Prisma" with 1 trials as a collaborator and "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Flinders University" are "Acute Myeloid Leukemia" (2 trials), "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials), "Autism Spectrum Disorder" (1 trials), "Breast Cancer Related Lymphoedema" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Flinders University" in a lesser frequency.

Most popular intervention types in "Flinders University" are "Drug" (4 trials), "Biological" (3 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AG-120" (1 trials), "AG-221" (1 trials), "Advax1" (1 trials), "Advax2" (1 trials) and "Commercial Hepatitis B vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Flinders University" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Flinders University". 1 are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Flinders University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Flinders University, 4 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".